International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.

Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D.

Open source

DOI
10.1124/pr.118.015552
Published
2021-01-01
Container
Pharmacol Rev
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1124/pr.118.015552,
  title = {International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.},
  author = {Barnes NM and  Ahern GP and  Becamel C and  Bockaert J and  Camilleri M and  Chaumont-Dubel S and  Claeysen S and  Cunningham KA and  Fone KC and  Gershon M and  Di Giovanni G and  Goodfellow NM and  Halberstadt AL and  Hartley RM and  Hassaine G and  Herrick-Davis K and  Hovius R and  Lacivita E and  Lambe EK and  Leopoldo M and  Levy FO and  Lummis SCR and  Marin P and  Maroteaux L and  McCreary AC and  Nelson DL and  Neumaier JF and  Newman-Tancredi A and  Nury H and  Roberts A and  Roth BL and  Roumier A and  Sanger GJ and  Teitler M and  Sharp T and  Villalón CM and  Vogel H and  Watts SW and  Hoyer D.},
  year = {2021},
  journal = {Pharmacol Rev},
  doi = {10.1124/pr.118.015552},
  url = {https://doi.org/10.1124/pr.118.015552}
}

RIS

TY  - JOUR
TI  - International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.
AU  - Barnes NM
AU  -  Ahern GP
AU  -  Becamel C
AU  -  Bockaert J
AU  -  Camilleri M
AU  -  Chaumont-Dubel S
AU  -  Claeysen S
AU  -  Cunningham KA
AU  -  Fone KC
AU  -  Gershon M
AU  -  Di Giovanni G
AU  -  Goodfellow NM
AU  -  Halberstadt AL
AU  -  Hartley RM
AU  -  Hassaine G
AU  -  Herrick-Davis K
AU  -  Hovius R
AU  -  Lacivita E
AU  -  Lambe EK
AU  -  Leopoldo M
AU  -  Levy FO
AU  -  Lummis SCR
AU  -  Marin P
AU  -  Maroteaux L
AU  -  McCreary AC
AU  -  Nelson DL
AU  -  Neumaier JF
AU  -  Newman-Tancredi A
AU  -  Nury H
AU  -  Roberts A
AU  -  Roth BL
AU  -  Roumier A
AU  -  Sanger GJ
AU  -  Teitler M
AU  -  Sharp T
AU  -  Villalón CM
AU  -  Vogel H
AU  -  Watts SW
AU  -  Hoyer D.
PY  - 2021
JO  - Pharmacol Rev
DO  - 10.1124/pr.118.015552
UR  - https://doi.org/10.1124/pr.118.015552
ER  -

APA

NM, B., GP, A., C, B., J, B., M, C., S, C., S, C., KA, C., KC, F., M, G., G, D. G., NM, G., AL, H., RM, H., G, H., K, H., R, H., E, L., EK, L., M, L., FO, L., SCR, L., P, M., L, M., AC, M., DL, N., JF, N., A, N., H, N., A, R., BL, R., A, R., GJ, S., M, T., T, S., CM, V., H, V., SW, W., & D., H. (2021). International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.. Pharmacol Rev. https://doi.org/10.1124/pr.118.015552

Source records